Gainers
- Rallybio RLYB shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million.
- Vera Therapeutics VERA shares increased by 10.52% to $46.0. The market value of their outstanding shares is at $2.5 billion.
- Biophytis BPTS stock rose 9.49% to $0.37. The company's market cap stands at $4.2 million.
- IMAC Hldgs BACK shares rose 7.35% to $3.02. The company's market cap stands at $3.4 million.
- Relay Therapeutics RLAY stock moved upwards by 7.1% to $7.39. The company's market cap stands at $969.4 million.
- Adial Pharmaceuticals ADIL shares rose 6.43% to $2.48. The company's market cap stands at $10.0 million.
Losers
- CytomX Therapeutics CTMX stock fell 7.2% to $1.95 during Wednesday's after-market session. The market value of their outstanding shares is at $132.0 million.
- Orgenesis ORGS shares declined by 5.74% to $0.49. The company's market cap stands at $16.7 million.
- OneMedNet ONMD shares fell 4.81% to $0.64. The market value of their outstanding shares is at $20.6 million.
- Fate Therapeutics FATE shares fell 4.31% to $6.0. The market value of their outstanding shares is at $682.6 million.
- Biolase BIOL stock decreased by 3.94% to $0.15. The company's market cap stands at $4.9 million.
- ABVC BioPharma ABVC stock decreased by 3.46% to $1.1. The company's market cap stands at $11.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ADILAdial Pharmaceuticals Inc
$0.96530.55%
BACKIMAC Holdings Inc
$1.25-5.30%
BIOLBiolase Inc COM PAR $.001 NEW
$0.0680291.9%
CTMXCytomX Therapeutics Inc
$0.87804.52%
FATEFate Therapeutics Inc
$1.334.72%
ONMDOneMedNet Corp
$1.3113.0%
ORGSOrgenesis Inc
$1.15-17.3%
RLAYRelay Therapeutics Inc
$4.674.71%
RLYBRallybio Corp
$0.89402.15%
VERAVera Therapeutics Inc
$33.801.29%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in